Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Presentation TCT 2023

The Spectrum of Calcium in In-Stent Restenosis

Presenter: Gary Mintz

October 26, 2023

Presentation TCT 2023

TCT 800: Is there a good time to deal with massive Left Main bifurcation calcium nodule? Case of restenosis after primary PCI of calcified lesion sucesfully trated with intravascular lithotrypsy and provissional stenting

Presenter: Piotr Pawluczuk

October 25, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

TCT 699: Preclinical evaluation of a thin-strut biodegradable stent in a porcine coronary artery restenosis model

Presenter: Piotr Buszman

October 25, 2023

Presentation TCT 2023

TCT 184: Treatment of Side Branch Restenosis after 1-stent Cross-over Stenting for Left Main Bifurcation Lesions

Presenter: Bom Lee

October 25, 2023

Presentation TCT 2023

Case 1: DCB for In-Stent Restenosis

Presenter: Rony Mathew

October 25, 2023

Presentation TCT 2023

TCT 813: DEB for In-stent restenosis, Size disparity and ostial lesions

Presenter: CHAKRABHAVI KESHAVAMURTHY

October 24, 2023

Presentation TCT 2023

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

Presenter: Parth Parikh

October 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

Advertisement

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

TCTMD’s Top 10 Most Popular Stories for October 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

The Spectrum of Calcium in In-Stent Restenosis

TCT 800: Is there a good time to deal with massive Left Main bifurcation calcium nodule? Case of restenosis after primary PCI of calcified lesion sucesfully trated with intravascular lithotrypsy and provissional stenting

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

TCT 699: Preclinical evaluation of a thin-strut biodegradable stent in a porcine coronary artery restenosis model

TCT 184: Treatment of Side Branch Restenosis after 1-stent Cross-over Stenting for Left Main Bifurcation Lesions

Case 1: DCB for In-Stent Restenosis

TCT 813: DEB for In-stent restenosis, Size disparity and ostial lesions

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

What’s Going to Be Hot at TCT 2023

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content